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Abstract
Purpose: To ask whether highly metastatic sublines show more marked low-dose hyper-radiosensitivity (HRS) response
than poorly metastatic ones.
Materials and methods: The progressive (PRO) subline showing tumourigenicity and metastatic potential and the regressive
(REG) subline showing neither tumourigenicity nor metastatic potential were both isolated from a parental rat colon
tumour. Clonogenic survival, micronuclei and apoptosis, cell cycle distribution, DNA single- (SSB) and double-strand
breaks (DSB) induction and repair were examined.
Results: HRS phenomenon was demonstrated in PRO subline. Before irradiation, PRO cells show more spontaneous
damage than REG cells. After 0.1 Gy, PRO cells displayed: (i) More DNA SSB 15 min post-irradiation, (ii) more
unrepaired DNA DSB processed by the non-homologous end-joining (NHEJ) and by the RAD51-dependent recombination
pathways, (iii) more micronuclei, than REG cells while neither apoptosis nor p53 phosphorylation nor cell cycle arrest was
observed in both sublines.
Conclusions: HRS response of PRO subline may be induced by impairments in NHEJ repair that targets G1 cells and
RAD51-dependent repair that targets S-G2/M cells. The cellular consequences of such impairments are a failure to arrest in
cell cycle, the propagation of damage through cell cycle, mitotic death but not p53-dependent apoptosis. Tumourigenic cells
with high metastatic potential may preferentially show HRS response.
Keywords: Low-dose hyper-radiosensitivity, DNA repair, cell cycle, cell death, micrometastases
Introduction
Among each type of tumour, the required tumour
lethal dose varies most commonly by a two-three
factor (Friedman 1975). Radiobiological features of
such intra-tumour heterogeneity have been recently
highlighted by in vitro studies supporting that cells
within a given tumour cell line show low-dose hyper-
radiosensitivity (HRS) that is replaced by induced
radioresistance (IRR) at a cell-line-dependent
threshold of 10–30 cGy. Such a conclusion was
reached after analyzing more than 40 tumour cell
lines (Skov 1999, Joiner et al. 2001, Marples et al.
2004). Micrometastases elicit higher genetic
instability and heterogeneity than primary tumours
(Tortola et al. 2001, Klein et al. 2002). However,
whether micrometastases may preferentially show
more HRS response than primary tumours is not
well documented. In addition, only few models of
micrometastases or spontaneous metastatic clones
deriving from the same parental tumor cell line are
available.
By using seven highly and poorly metastatic clones
derived from the same parental human melanoma
cell line, we have previously shown that the more the
clones show marked HRS response, the more the
clones are metastatic (Thomas et al. 1997). HRS was
also reported in human metastatic skin nodules
(Harney et al. 2004). Hence, these findings suggest
that the higher the HRS response, the higher the
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tumourigenicity. Besides, it is noteworthy that HRS
is not a common finding in human normal cells
(Slonina et al. 2007). The fact that highly metastatic
cells may preferentially show more HRS response
than poorly metastatic ones suggests that HRS
response should be considered more carefully in
the radiotherapy of micrometastases (Thomas et al.
2007).
Although a number of molecular models have
been proposed, mechanisms of HRS are still unclear
(Skov 1999, Joiner et al. 2001, Marples et al. 2004).
It has been suggested that HRS may depend upon
changes in chromatin conformation (Joiner et al.
2001), failure of the ATM-dependent G2/M check-
point (Marples et al. 2004), DNA repair defects
(Vaganay-Juery et al. 2000, Short et al. 2005) and/or
induction of p53-dependent apoptosis (Enns et al.
2004). The DNA repair field has recently pro-
gressed, especially for DNA DSB. Notably, impair-
ments of the major DNA DSB repair pathways, the
non-homologous end-joining (NHEJ) and the
RAD51-dependent recombination, result in high
radiosensitivity and cancer proneness, respectively
(Joubert & Foray, 2006, Joubert et al. 2008). Finally,
a functional and temporal hierarchy between ATM-
dependent phosphorylation events occurring early
after irradiation has been demonstrated: such phos-
phorylations may determine success of DNA repair,
cell cycle arrests and cell death (Foray et al. 2003).
Here, by using such endpoints, we examined
whether HRS response is higher in tumorigenic cells
with high metastatic potential than in non-tumori-
genic cells. The previously described PRO and REG
sublines that derived from the same parental rat
colon tumour were chosen as a model (Martin et al.
1983).
Materials and methods
Cells and irradiation
PRO and REG sublines were kindly provided by Dr
F. Martin (Dijon, France). PRO and REG sublines
were isolated from the parental tumour cell line
DHD-K12, established from dimethylhydrazine-in-
duced colon carcinoma in syngeneic BDIX rats
(Martin et al. 1983). PRO and REG sublines have
been isolated according to their sensitivity to trypsin-
mediated detachment from plastic surface (PRO
subline is more trypsin-resistant than REG subline).
PRO and REG cells show different immunogenicity
and tumorigenicity in syngeneic hosts. When grafted
subcutaneously in BDIX rats, REG cells produced
regressive tumours disappearing within 3–4 weeks
while PRO cells produced progressive tumours in
60% of animals (Martin et al. 1983). Metastases to
lungs, kidney or lymph nodes were observed in more
than 50% of rats in which PRO tumour was either
allowed to grow for four months or excised 2–4
weeks after inoculation (Martin et al. 1983). In
contrast, neither syngeneic BDIX rats nor nude mice
that are inoculated with REG cells produced
metastases (Martin et al. 1983). PRO and REG
sublines were cultured in Roswell Park Memorial
Institute (RPMI) 1640 medium with 2 mM gluta-
mine, 10% decomplemented fetal bovine serum and
antibiotics (1% penicillin, streptomycin) (Gibco-
Invitrogen-France, Cergy-Pontoise, France). Cells
were mycoplasma-free and maintained at 378C at 5%
CO2 for no more than five passages. For all the
assays described below, confluent PRO and REG
cultures were softly detached with 0.025%
trypsin and 0.02% ethylenediaminetetraacetic acid
(EDTA) (Gibco-Invitrogen-France, Cergy-Pontoise,
France) to obtain single cell suspensions. Irradia-
tions were performed either with 60Co g-rays at a
dose rate of 0.5 Gy min71 (clonogenic assay, comet
assay) or with X-rays produced by two irradiators
(immunofluorescence and cell cycle assays): a Philips
BV212 mobile surgical system (100 kV, 3 mA)
delivering 0.1 Gy at a dose rate of 0.17 Gy min71
and a clinical irradiator (200 kV, 20 mA) delivering
6 Gy at a dose rate of 1.25 Gy min71. It is
noteworthy that 60Co g-rays, 100 kV and 200 kV
X-rays induce the same DNA DSB induction rate
(data not shown).
Clonogenic survival assay
Clonogenic survival was assessed as previously
described (Thomas et al. 1997). Briefly, 500 cells
were seeded and irradiated 2 or 24 h after plating
with doses ranging from 0.05–6 Gy. Colonies
were fixed and stained with standard crystal violet
solution (Sigma-Aldrich-France, L’Isle d’Abeau,
France) incubation without change of medium. Only
colonies showing more than 50 cells were consid-
ered. Plating efficiencies of unirradiated REG and
PRO cells were 30+ 1.4% (mean+SEM (standard
error of the mean), n¼ 21) and 23+ 1% (mean+
SEM, n¼ 23), respectively. In order to examine
whether, before irradiation, cellular proliferation may
impact upon HRS response, multiplicity assay was
applied. To this aim, cells were fixed and stained
with crystal violet 24 h after plating: in such
conditions, the cell multiplicity (i.e., the number of
cells per colony-forming unit) was found to be closed
to one.
Survival curves analysis
Surviving fractions (SF) were fitted to three models:
The one population linear-quadratic (LQ) model,
the induced repair (IR) model (Lambin et al. 1994)
534 C. Thomas et al.
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and the two populations linear-quadratic (2-pop LQ)
model (Thomas et al. 1997) defined by, respectively:
(1) SFðDÞ ¼ e a Dþb D
2ð Þ
(2) SFðDÞ ¼ e
ar 1þ
as
ar
1ð Þ  e
D
dc
h i
Dbr D
2
(3) SFðDÞ ¼ 1 lð Þ  eas D þ l  e ar Dþbr D
2ð Þ
The IR model is a modified version of the LQ model
in which the a term is dependent on dose (D): at very
low doses, a is large, and it decreases with increasing
dose in an exponential manner at a rate determined
by a constant dc. The parameter as represents the
initial slope of the curve at very low doses, ar
represents the value extrapolated from the conven-
tional high-doses response, dc represents the dose
that induced the change from HRS to IRR. The
occurrence of HRS/IRR is mathematically deduced
from as and ar values that do not coincide and dc
values significantly greater than zero (Table I). With
regard to the 2-pop LQ model that assumed the
existence of two subpopulations of cells with
different radiosensitivity, the l parameter represents
the proportion of radioresistant cells. The as para-
meter is linked to the radiosensitive subpopulation.
The ar, br parameters are linked to the radioresistant
subpopulation. All the survival data were fitted
by using the JMP Software (version 2.0.5, SAS
Institute, Cary, NC, USA).
Alkaline comet assay
The experimental protocol for the alkaline comet
assay was previously described (Alapetite et al. 1996)
and was applied here with minor modifications.
Briefly, cells embedded in agarose (Sigma) were
irradiated 2 h after plating on slides that were
maintained on ice for at least 30 min before
irradiation and protected from direct natural light
during all following steps. For the assessment of
initial DNA SSB, slides were immersed immediately
after irradiation at doses ranging from 0.05–6 Gy for
1 h in lysis solution (2.5 M NaCl, 100 mM EDTA,
10 mM tris-hydroxymethylaminomethane, 1% N-
laurylsarcosine, 1% Triton X-100, 10% dimethyl-
sulfoxide, pH 10, 48C) (Sigma-Aldrich-France,
L’Isle d’Abeau, France). For the assessment of
residual DNA SSB, slides were incubated after
irradiation at 0.1 and 6 Gy in complete medium at
378C for 15 min, 1 and 14 h before lysis. Slides were
transferred to electrophoresis box containing alkaline
buffer (300 mM NaOH, 1 mM EDTA, pH 13)
(Sigma-Aldrich-France, L’Isle d’Abeau, France) for
40 min to allow DNA unwinding. Electrophoresis
was performed for 20 min (25 V, 300 mA). Slides
were rinsed twice for 5 min with neutralization buffer
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(0.4 M Tris, pH 7.5), stained with 8 ng  ml71
ethidium bromide (Sigma-Aldrich-France, L’Isle
d’Abeau, France) and kept at 48C. Comets were
observed with Leica fluorescence microscope and
analyzed with the image analysis Komet software
(Kinetic imaging 4.0, Andor technology, South
Windsor, CT, USA). Comets were evaluated by tail
moment defined as product of tail DNA percent and
tail length. The tail moment of irradiated cells was
divided by the tail moment of unirradiated cells to
provide the normalized tail moment. Cells were
considered as highly damaged cells (HDC) if the
normalized tail moment was higher than 90%. In
each experiment, 15 comets per slide were randomly
captured at constant gel depth, by avoiding gel edge
and superimposed comets. Each experiment was
replicated three times and 45 comets were consid-
ered per dose.
Immunofluorescence assay
This assay already described (Foray et al. 2003) was
applied with minor modifications. Briefly, 56 105
cells were seeded on slides and incubated for 24 h in
complete medium at 378C. After irradiation at 0.1
Gy, dishes were incubated at 378C for 10 min, 1 h,
24 h and 48 h while after irradiation at 6 Gy, dishes
were incubated for 24 h only. Cells were fixed in
paraformaldehyde solution for 15 min at room
temperature and permeabilized for 90 s at 48C in
lysis solution (20 mM 4-(2-hydroxyethyl)-1-pipera-
zine ethanesulfonic acid (HEPES) (pH 7.4), 50 mM
NaCl, 3 mM MgCl2, 300 mM sucrose, 0.5% Triton
X-100) (Sigma-Aldrich-France, L’Isle d’Abeau,
France). Primary antibody incubations were per-
formed for 40 min at 378C. Anti-pH2AXser139 anti-
body (#05636; Upstate Biotechnology-Euromedex,
Mundolsheim, France) was used at 1:800.
Anti-pATMser1981 (#2888; Abcam, Cambridge,
UK), -pDNA-PKthr2609 (#ab4194; Abcam,
Cambridge, UK), -pH3ser10 (#ab14955; Abcam,
Cambridge, UK), -MRE11 (#56211; Abcys, Paris,
France) and -pP53ser15 (#9284; Cell Signalling,
Beverly, USA), and -RAD51 (#8349; Santa-Cruz-
Biotechnologies, Santa-Cruz, USA) were used at
1:100. Incubations with anti-mouse fluorescein
(green) or rhodamin (red) secondary antibodies were
performed at 1:100 at 378C for 20 min. Slides were
mounted in 40,6-diamidino-2-phenylindole (DAPI)-
stained Vectashield (Abcys, Paris, France) and 100
cells per slide were examined with Olympus fluores-
cence microscope. DAPI staining permitted to
indirectly evaluate yield of G1 cells (nuclei with
homogeneous DAPI staining), S cells (nuclei show-
ing numerous pH2AX foci), G2 cells (nuclei with
heterogeneous DAPI staining) and metaphase (visi-
ble chromosomes). DAPI staining permitted also to
quantify the percentage of cells with micronuclei by
examining 100 cells at least.
Cell cycle analysis
PRO and REG cells were seeded at 56 105 cells per
dish and showed similar doubling time of about
36 h. Twenty-four hours after plating, cells were
irradiated at 0.1 and 6 Gy. Fifteen min, 1 h, 6 h and
24 h after irradiation at 0.1 Gy and 15 min and 24 h
after irradiation at 6 Gy, cells were trypsinized, fixed
in 70% ethanol and stored at 7 208C. At least 104
fixed cells treated with 10 mg ml71 RNAse A and
20 mg ml71 propidium iodide (Sigma-Aldrich-
France, L’Isle d’Abeau, France) were analyzed using
cytometer (Beckton Dickinson, Pont-de-Claix,
France). Cell cycle distribution was quantified with
WinMDI software (Scripps-Research-Institute, La
Jolla, USA).
Results
HRS response and cell cycle distribution
Since it was suggested that G2 phase cells may
explain the HRS response (Marples et al. 2004),
cell cycle distribution and cell survival were both
examined in PRO/REG cells. As a first step, the
HRS response was examined by irradiating PRO/
REG cells 2 h after plating. HRS response varied
greatly according to the different experiments. PRO
and REG cells showed HRS response in 9 among
11 and 3 among 9 independent experiments,
respectively (Figure 1A, 1B). These data suggest
that PRO cells display more HRS response than
REG cells when cells are irradiated 2 h after
plating. Twenty-four hours after plating, PRO cells
also showed HRS response whereas REG cells did
not. Moreover, the initial part of the survival curve
(i.e., the HRS response) was similar in PRO cells
whether irradiated 2 h or 24 h after plating
(Figure 1C). Survival data shown in Figure 1C
were fitted to the LQ, 2-pop LQ and IR models. It
appeared that the HRS response in PRO cells was
better described by the IR model than by the 2-pop
LQ model. This was notably verified in the low-
dose range for PRO cells irradiated 24 h after
plating in which the as parameter of the 2-pop LQ
model was unable to be determined by the fitting
analysis (Table I). PRO cells irradiated 2 h or 24 h
after plating showed as/ar ratios of 5 and 7,
respectively (Table I). Thus, the HRS response in
PRO cells irradiated 2 h after plating was similar to
that obtained in PRO cells irradiated 24 h after
plating. By contrast, REG cells did not show any
significant HRS response, whatever the time after
plating (Table I).
536 C. Thomas et al.
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We examined thereafter whether the percentage of
G2/M cells evaluated before irradiation (i.e., 2 h or
24 h after plating) impacts upon the HRS response.
Unirradiated PRO subline showed significantly less
cells in G2/M 2 h after plating and significantly more
cells in G2/M 24 h after plating than REG subline.
Furthermore, since: (i) Unirradiated PRO subline
showed significantly more cells in G2/M 24 h after
plating than 2 h after plating (Figure 2A, left panel);
(ii) PRO cells showed similar HRS response 2 h and
24 h after plating; and (iii) no significant HRS
response was observed in REG cells whatever the
time after plating (Figure 1C), our data suggest that
the percentage of G2/M cells before irradiation
cannot explain the difference in HRS response
between PRO and REG sublines.
Cell cycle distributions were also examined in cells
irradiated 24 h after plating at 0.1 Gy and 6 Gy. A
low-dose of 0.1 Gy was chosen to evaluate specifi-
cally the HRS and not the IRR response since the
dose inducing the transition from HRS to IRR (dc)
was 0.19+ 0.08 Gy for PRO cells irradiated 24 h
after plating (Table I). A high-dose of 6 Gy that
provided the largest survival difference between PRO
and REG cells was chosen to compare data obtained
after irradiation at 0.1 Gy. Fifteen min, 1, 6 and 24 h
after irradiation at 0.1 Gy, cell cycle distributions in
PRO and REG cells remained unchanged compared
to those observed in unirradiated cells, suggesting
that a dose of 0.1 Gy is not sufficient to trigger
significant cell cycle change whatever the subline
(data not shown). By contrast, 24 h after irradiation
at 6 Gy, the S fraction significantly decreased in both
sublines whereas the G2/M fraction significantly
increased in PRO cells only when compared to
unirradiated cells (Figure 2A, right panel).
DAPI staining and immunofluorescence per-
formed with antibodies against phosphorylated H3
histone forms characterizing mitoses were also
applied during immunofluorescence experiments in
parallel to cytometry analysis. Mitotic cells repre-
sented less than 5% of cells and this feature remained
unchanged after irradiation at 0.1 Gy (Figure 2B),
consolidating therefore the cytometry data described
above (Figure 2A). Hence, altogether, these findings
suggest that the relative fraction of G2/M cells alone
cannot explain the HRS response observed in PRO/
REG sublines.
Cell death
Clonogenic death is the final result of different
radiation-activated death pathways such as apoptosis,
mitotic death or senescence. We asked whether
particular cell death pathway may explain the HRS
response observed in PRO cells. By examining
DAPI-stained cells with immunofluorescence, no
apoptotic body was observed either between 15 min
and 48 h after irradiation at 0.1 Gy or 24 h after
irradiation at 6 Gy in PRO and REG cells (data not
shown). Apoptosis can be mediated by p53-depen-
dent and -independent pathways. However, since
Figure 1. Survival curves of PRO/REG cells. Experiments were
performed with cells cultured for no more than five passages. PRO
cells (A) and REG cells (B) were irradiated 2 h after plating.
Eleven and nine independent experiments were performed for
PRO cells and REG cells, respectively. Only data fits to the most
relevant model were represented for each experiment (LQ: dashed
line; IR: continuous line). (C) Survival curves of PRO/REG cells
irradiated 2 h and 24 h after plating. Each data plot represents the
mean+SEM of 11 and 9 independent experiments for PRO and
REG cells irradiated 2 h after plating, respectively and the
mean+SEM of three and two independent experiments for
PRO and REG cells irradiated 24 h after plating, respectively.
Data fits to the most relevant model were represented for each cell
line (LQ: dashed line; IR: continuous line). Insert shows a zoom of
survival curves at doses below 1 Gy.
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Figure 2. Cell cycle distribution in PRO/REG cells. (A) Left panel. Relative cell cycle distribution in unirradiated PRO/REG cells before
irradiation, i.e., 2 h or 24 h after plating. *p5 0.05 and **p50.05 for comparison of data between unirradiated PRO cells and unirradiated
REG cells 2 h and 24 h after plating, respectively and *p50.05 for comparison between unirradiated PRO cells 2 h after plating to
unirradiated PRO cells 24 h after plating using t-test. Right panel. Relative cell cycle distribution in PRO/REG cells 24 h after irradiation at 6
Gy. *p50.05 and **p5 0.05 for comparison of data between irradiated PRO and REG cells to unirradiated PRO and REG cells,
respectively using t-test. Each data corresponds to the mean+SEM of four independent experiments. (B) Immunofluorescence data
obtained with antibodies against phosphorylated histone H3 in PRO cells and REG cells. Upper panel shows a representative example of
mitosis stained in fluorescein (green) and clearly identifiable in DAPI. This picture was obtained with the 1006microscope objective (the
white bar represents 5 mm). Lower panel shows representative pictures with green-stained mitoses 10 min and 24 h after irradiation at
0.1 Gy in PRO/REG cells as observed in 106microscope objective (the white bar represents 0.05 mm).
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p53-dependent apoptosis has been evoked to explain
the HRS phenomenon (Enns et al. 2004), the
occurrence of phosphorylated forms of p53 (pP53)
was investigated by using specific immunofluores-
cence after irradiation at 0.1 Gy and 6 Gy. Whereas
pP53 appeared essentially cytoplasmic in both
unirradiated PRO and REG cells, it was nuclear in
rodent control cells. Four hours after irradiation at
0.1 Gy, pP53 localization did not change in PRO and
REG cells (Figure 3A). Similar conclusions were
reached 24 h after irradiation at 6 Gy (data not
shown). These data suggest a functional impairment
of p53 in both unirradiated and irradiated PRO/REG
cells, consistent with absence of p53-dependent
apoptosis. At this stage, it must be stressed that
these results do not necessarily mean that the p53
protein is mutated in both sublines or that p53
mutations are similar. These results only provide
information about the functionality of the ATM-
dependent phosphorylation of p53 that impacts upon
cell cycle control and p53-dependent apoptosis.
Mitotic death is characterized by micronuclei
formation. No cell with micronuclei was observed
in unirradiated cultures. Forty-eight hours after
irradiation at 0.1 Gy, the percentage of cells showing
one micronucleus was 37+ 5% and 2+0.3%
(mean+SEM, n¼ 3) in PRO and REG cells,
respectively (Figure 3B). Such numbers are much
higher than those previously obtained by Slonina et al.
(2007) in irradiated primary human fibroblasts with a
mean of 1.7% and a range of 0.3–3.8%. However, it is
noteworthy that capacity of proliferation, distribution
in cell cycle, cell type and origin are deeply different
(human fibroblasts versus rodent tumour cells), which
may explain, at least in part, such a difference.
Corresponding surviving fraction for PRO and REG
cells irradiated 24 h after plating with 0.1 Gy X-rays
were 0.85+ 0.04 (mean+SEM, n¼ 6) and
1.1+0.07 (mean+SEM, n¼ 6), respectively. Data
support that mitotic death, more likely than p53-
dependent apoptosis, reflects HRS response in PRO
cells. Since micronuclei result from propagation of
unrepaired DNA breaks throughout cell cycle, DNA
breaks in PRO/REG cells have been investigated.
DNA SSB induction and repair
From the analysis of 45 comets, the mean and the
SEM of the tail moments in unirradiated PRO and
REG cells were 66+ 10 and 86+ 14, respectively.
Figure 3. The p53-dependent apoptosis and the mitotic death in PRO/REG cells. (A) Anti-pP53 immunofluorescence performed in PRO
and REG cells. Cells were either unirradiated (controls) or irradiated at 0.1 Gy followed by 4 h for repair. Chinese Hamster Ovary (CHO)
cells were used as positive controls. (B) Micronuclei of PRO cells observed 48 h after irradiation at 0.1 Gy. No significant number of
micronuclei was observed in REG subline whether in unirradiated cells or in irradiated cells 48 h after irradiation at 0.1 Gy.
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These data suggest that the yield of spontaneous
DNA SSB does not discriminate the PRO/REG
sublines. Normalized tail moment (NTM) was
chosen as an endpoint for describing the radiation-
induced initial (i.e., assessed immediately after
irradiation) and residual DNA SSB. The higher
the dose, the higher the yield of initial DNA SSB
(Figure 4A). However, such linear relationship did
not display significant difference between PRO and
REG cells. Indeed, although the yield of DNA SSB
assessed immediately after irradiation at 0.1 and 6
Gy in PRO cells was significantly higher than that
obtained in unirradiated cells, this endpoint was not
significantly different in PRO and REG cells (data
not shown), suggesting that initial DNA SSB cannot
explain the difference observed in HRS response
between PRO and REG cells.
During comet experiments, the presence of some
cells highly damaged cells (HDC) may be noticed
(Olive et al. 1993). In our conditions, a substantial
fraction of HDC was observed in REG cells but not
in PRO cells before irradiation with a median of 7%
and 0% and ranges of (0–33%) and (0–0%),
respectively. HDC were observed in PRO and
REG cells immediately after irradiation but not
between 15 min and 24 h post-irradiation (data not
shown). When HDC were omitted from NTM data,
the yield of initial DNA SSB as function of dose was
similar in both sublines (data not shown). The
biological significance of HDC is not clear. HDC
may reflect transient but significant disturbances in
chromatin since comet assay is prominently influ-
enced by chromatin organization (e.g., Kumar et al.
2002). It was also suggested that HDC may be
apoptotic cells occurring rapidly after irradiation
(e.g., Olive et al. 1993). However, no apoptotic body
was observed between 15 min and 48 h after
irradiation at 0.1 and 6 Gy in both sublines. Lastly,
the number of HDC was neither correlated with
radiation doses nor with surviving fractions in both
sublines (data not shown). Altogether, these data
suggest therefore that, like initial DNA SSB, HDC
cannot explain the difference in HRS response
between PRO and REG cells.
With regard to residual DNA SSB, NTM assessed
15 min after irradiation at 0.1 Gy was significantly
higher in PRO cells than in REG cells while no
significant difference between irradiated and uni-
rradiated PRO/REG sublines data was observed for
longer times after irradiation at 0.1 Gy (Figure 4B).
Furthermore, PRO cells showed three-fold more
DNA SSB 15 min after irradiation at 6 Gy than REG
cells (data not shown), suggesting a production of
additional DNA SSB after irradiation. Altogether,
these data showed that after irradiation at 0.1 and 6
Gy, there is no significant difference in initial and
residual DNA SSB between both sublines, to the
notable exception of a DNA SSB burst observed
15 min after irradiation in PRO cells only.
Induction and repair of DNA DSB processed by the
NHEJ pathway
DNA DSB induction and repair were examined by
using immunofluorescence with specific antibodies
Figure 4. Initial and residual DNA SSB. (A) Initial DNA SSB.
The number of DNA SSB assessed immediately after irradiation in
PRO/REG cells was expressed as normalized tail moment (NTM).
Each data representing the mean+SEM of three independent
experiments was plotted against the corresponding radiation dose.
NTM was found to be linearly linked to the dose for PRO/REG
sublines (R2¼0.81, p5 0.001 and R2¼0.52, p50.05, respec-
tively). (B) Residual DNA SSB. The number of DNA SSB assessed
at the indicated times after irradiation at 0.1 Gy in PRO/REG cells
was expressed as NTM. Each data represents the mean+SEM of
three independent experiments. Asterisk corresponds to a sig-
nificant difference (p50.05) between PRO and REG cells by
using the t-test.
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against H2AX phosphorylation (pH2AX), an early
NHEJ event (Rothkamm & Lo¨brich 2003). The
number of spontaneous pH2AX foci was not
significantly different in both sublines. Ten min
and 1 h after irradiation at 0.1 Gy, the number of
pH2AX foci per cell was significantly higher in PRO
cells than in REG cells. Furthermore, 24 h after
irradiation at 0.1 Gy, the number of pH2AX foci per
cell was significantly higher in irradiated PRO
cells than that obtained in unirradiated PRO cells
(Figure 5A). Such a difference in DSB repair rate
was confirmed 24 h after irradiation at 6 Gy (data
not shown), suggesting an impairment of the NHEJ
process in PRO cells but not in REG cells.
Since ATM and DNA-PK kinases are responsible
for the H2AX phosphorylation, the radiation-
induced kinase activity was evaluated by using
antibodies against autophosphorylated ATM and
DNA-PK forms that re-localize as nuclear foci
(pATM and pDNA-PK, respectively). The number
of pDNA-PK and pATM foci in PRO cells was
similar to that observed in REG cells after irradiation
at 0.1 Gy but higher to that obtained in REG cells
after irradiation at 0.2 Gy (Figure 5B). Hence, these
findings suggest that the HRS response observed in
PRO cells after irradiation at 0.1 Gy cannot be
explained by impaired ATM and/or DNA-PK kinase
activities required for the DNA DSB recognition
during the NHEJ process.
The MRE11 protein, associated with hyper-
recombination and genomic instability (Joubert &
Foray 2006; Joubert et al. 2008), was found
essentially cytoplasmic in both sublines, while a
rodent control showed a normal formation of
radiation-induced MRE11 nuclear foci, suggesting
that the HRS response in PRO cells is MRE11-
independent (data not shown).
Induction and repair of DNA DSB processed by
RAD51-dependent recombination pathway
While NHEJ is the major DNA DSB repair
pathway acting in G1 cells, DNA DSB in S-G2/M
cells are more likely repaired by the RAD51-
dependent recombination. Since radiation-induced
RAD51 foci are generally tiny and numerous, the
percentage of cells showing RAD51 foci rather than
their yield per cell was chosen as endpoint. Unlike
with pH2AX assay, the percentage of cells showing
spontaneous RAD51 foci was five-fold higher in
PRO cells than in REG cells (data not shown). A
similar conclusion was reached 4 h after irradiation
at 0.1 Gy. At such dose, RAD51 remained
cytoplasmic in REG cells, suggesting that this
protein was activated after 0.1 Gy in PRO cells
only (Figure 6A). By contrast, after irradiation at 6
Gy, 90% of REG cells and 30% of PRO cells
elicited RAD51 foci (Figure 6A). Since RAD51-
dependent repair is active in S-G2/M cells only, the
relationship between RAD51 data and the corre-
sponding cell cycle distributions was investigated.
Before irradiation, the percentages of S-G2/M cells
in both sublines were similar before irradiation
(57+ 2% and 51+ 6% (mean+SEM, n¼ 4) in
PRO and REG cells, respectively) (Figure 2A).
After irradiation at 0.1 and 6 Gy, a significant linear
relationship was detected between the percentage of
cells showing RAD51 foci and the percentage of S-
G2/M cells in PRO cells but not in REG cells
(Figure 6B), suggesting that unrepaired DNA DSB
processed by the RAD51-dependent repair pathway
may propagate through the cell cycle in PRO cells
but not in REG cells.
Discussion
PRO/REG sublines: A useful model to study HRS
response
PRO/REG sublines have been deliberately chosen to
test whether HRS response is more marked in
tumorigenic cells with high metastatic potential than
in non-tumorigenic cells with no metastatic poten-
tial. PRO/REG sublines were obtained from the
same parental rat colon tumour, which made
possible molecular and cellular investigations on
HRS response in the frame of tumour heterogeneity.
Here, our data indicate that PRO cells show more
HRS response than REG cells, consistently with
literature showing that tumorigenic cells are gener-
ally more radiosensitive than non-tumorigenic cells
(e.g., Barnetson et al. 1999). Our observations
provide evidence that neither cell cycle distribution
alone (both sublines elicited similar S-G2/M fraction
before irradiation) nor p53-dependent apoptosis (not
relevant here) nor HDC (REG cells spontaneously
showed more HDC than PRO cells) may explain the
fact that PRO cells show higher HRS response than
REG cells.
Impact of the major DNA repair pathways upon HRS
response
Induction and repair of DNA SSB and DSB were
investigated by using alkaline comet and pH2AX,
pATM, pDNA-PK, MRE11 and RAD51 immuno-
fluorescence assays. Alkaline comet assay allowing
the assessment of initial and residual DNA SSB has
been already applied to low-dose (6 mGy) (Malyapa
et al. 1998) or very-low chronic radiation dose-rate
(20 mSv  h71) (Meehan et al. 2004). The H2AX
assay that allows the detection of DNA DSB has
already proved its efficiency at very low-dose like 1.2
mGy (Rothkamm & Lo¨brich 2003).
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Figure 5. Initial and residual DNA DSB processed by the NHEJ repair pathway. (A) Left panel. DSB induction and repair after irradiation at
0.1 Gy. The number of pH2AX foci per cell was plotted against the post-irradiation times. Each data represents the mean+SEM of two
independent experiments. #p5 0.05 and *p50.05 for comparison of data between irradiated PRO and REG cells and between irradiated
PRO cells and unirradiated PRO cells, respectively using t-test. Right panel. Representative pH2AX signals provided by PRO/REG cells
10 min after irradiation at 0.1 Gy. (B) The number of pDNA-PK (left panel) and pATM (right panel) foci per cell assessed 10 min after
irradiation was plotted against the indicated radiation doses in PRO/REG sublines. Each data represents the mean+SEM of two
independent experiments. Corresponding representative pictures of pATM and pDNA-PK are shown below.
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With regard to spontaneous DNA damage, PRO
and REG sublines elicited similar yields of DNA
SSB and DSB recognized by alkaline comet and
pH2AX assays, respectively. Conversely, the RAD51
data revealed more spontaneous DNA damage in
PRO than in REG cells, which cannot be explained
by differences in the cell cycle distribution between
both sublines. Hence, these findings support that
such spontaneous DNA damage are processed in
PRO cells specifically by the RAD51-dependent
pathway but not by the NHEJ one. The RAD51-
dependent recombination pathway is able to manage
SSB and DSB, and unlike NHEJ, can produce DNA
SSB intermediates during the DNA DSB repair
process (Raderschall et al. 1999, Schlegel et al.
2006). Hence, we propose that S-G2/M PRO cells
are characterized by a lack of control in the RAD51
endonuclease function through hyper-recombination
Figure 6. DNA DSB processed by the RAD51-dependent recombination repair pathway. (A) Left panel. Representative RAD51 signals
obtained 4 h after irradiation at 0.1 Gy. Right panel. Percentages of cells with RAD51 foci assessed 4 h after irradiation are shown at the
indicated doses (0.1 and 6 Gy). Each data represents the mean+SEM of two independent experiments. *p5 0.05 and **p50.05 for
comparison of data between PRO cells and REG cells irradiated at 0.1 Gy and 6 Gy, respectively using t-test. (B) The percentages of cells
with RAD51 foci were plotted against the corresponding percentages of S-G2/M cells after irradiation at 0.1 and 6 Gy. Each data represents
the mean+SEM of two independent experiments for RAD51 data and four independent experiments for cell cycle data. A significant linear
correlation between RAD51 and cell cycle data was found for PRO cells (continuous line; R2¼ 0.94, p5 0.05) but not for REG cells
(dashed line).
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(e.g., Schultz et al. 2003). Whether the DNA SSB
burst observed 15 min after irradiation at 0.1 and 6
Gy in PRO cells is consistent with induction of DNA
SSB during repair of DNA DSB needs further
investigations. However, it raises the problem of
the impact of the cell cycle distribution upon the
evaluation of HRS response. Indeed, any impairment
of RAD51-dependent repair should not be visible in
quiescent cells. Interestingly, only two among forty
human primary fibroblasts elicit HRS response
(Slonina et al. 2007). This last observation might
be explained by the propensity of fibroblasts to be
essentially in G1 phase. A direct consequence of a
lack of control of RAD51-dependent repair would be
also that PRO cells elicit higher chromatin fragility
and genomic instability. Besides, the influence of
chromatin fragility was already demonstrated in the
radiosensitivity of some tumour cell lines (Chavau-
dra et al. 2004) and in ataxia telangiectasia or
Xeroderma Pigmentosum fibroblasts (Puvion-Dutil-
leul 7 Sarasin 1989).
With regard to radiation-induced DNA damage,
the data presented here suggest that the HRS
response in PRO cells may not be explained by an
impairment in DNA DSB recognition, in agreement
with data from Wykes et al. (2006). Along with this
normal DNA damage recognition, PRO and REG
sublines elicited after irradiation similar initial DNA
SSB yields but PRO cells showed significantly more
initial DNA DSB than REG cells, suggesting again
higher chromatin fragility in PRO cells.
With regard to unrepaired DNA DSB, PRO cells
displayed more impaired damage processed by the
NHEJ pathway after irradiation at 0.1 and 6 Gy than
REG cells. Such a conclusion is in agreement with
the relative defect of DNA DSB repair in fibroblasts
that show HRS response after irradiation at 1.2 mGy
(Rothkamm & Lo¨brich 2003). Besides, after irradia-
tion at 0.1 Gy, PRO cells displayed more unrepaired
DNA breaks processed by the RAD51 repair path-
way than REG cells, consistently with a previous
report showing that HRS response is associated with
an increase of the number of RAD51 foci per cell
after low-dose radiation (Short et al. 2005). Alto-
gether, the analysis of the radiation-induced DNA
damage after irradiation at 0.1 Gy suggests that more
numerous and less repairable DNA lesions occur in
PRO cells than in REG cells. Such phenomenon
concern the two major DNA breaks repair pathways:
NHEJ acting in G1 and the RAD51-dependent
recombination acting in S-G2/M.
Impact of the cell cycle distribution upon HRS response
It was suggested that G2 cells may dominate HRS
response, which may be specific to damaged cells
that fails to activate a transient G2/M checkpoint and
enter into mitosis with unrepaired DNA breaks
(Marples et al. 2004). Although the G2/M check-
point was not the scope of this study, our observation
that the cell cycle distribution in PRO cells after
irradiation at 0.1 Gy is similar to that of unirradiated
cells, may be consistent with a failure to induce
G2/M arrest after irradiation at low doses. Such a
conclusion is in agreement with previous reports
(Marples et al. 2003, Krueger et al. 2007b), although
we emphasized that the HRS response may not be
dominated by the fraction of G2/M cells only.
Experimental conditions may explain discrepancies
in literature, e.g., irradiation was performed with
cells in suspension that were plated after irradiation
(Marples et al. 2003, Krueger et al. 2007b) whereas,
in our study, irradiation was performed with
adherent cells.
Impact of the cell death pathway upon HRS response
Such cascade of impaired events would likely result
in micronuclei or apoptotic bodies. With PRO/REG
cells, our data suggest that unrepaired DNA breaks
induce mitotic death, but not p53-dependent
apoptosis. This conclusion is not in agreement with
the reports supporting that HRS response is
associated with p53-dependent apoptosis in other
tumour cell lines (Enns et al. 2004, Krueger et al.
2007a). Besides, whether HRS response is caused
by unrepaired DNA breaks inducing apoptosis and/
or mitotic death still remains controversial and,
again, likely depends upon: (i) The experimental
conditions (Joiner et al. 2001, Chandna et al. 2002,
Rothkamm & Lo¨brich 2003) and notably whether
cells were derived from exponential-phase or
plateau-phase cultures (Krueger et al. 2007a); and
(ii) the status of the genes and/or the functionality
of their corresponding proteins involved in HRS,
e.g., whether cells are p53-mutated or wild-typed
(Enns et al. 2004, Krueger et al. 2007a), normal
fibroblasts (Rothkamm & Lo¨brich 2003) or onco-
gene-transformed or DNA repair-deficient fibro-
blasts (Wykes et al. 2006).
Model for HRS response
We propose that the HRS response in PRO subline is
induced by both:
(1) An impairment of NHEJ repair in G1 cells. It is
noteworthy that impaired NHEJ is responsible
for intrinsic radiosensitivity whatever the dose.
Since it has been recently demonstrated that the
level of NHEJ impairment is quantitatively
predictive of intrinsic radiosensitivity (Joubert
& Foray 2006; Joubert et al. 2008), we suggest
that the level of NHEJ impairment may predict
544 C. Thomas et al.
D
o
w
n
lo
a
d
e
d
 B
y:
 [
Jo
in
t 
IL
L
 -
 I
n
st
itu
te
 L
a
u
e
-L
a
n
g
e
vi
n
] 
A
t:
 0
6
:5
7
 2
8
 J
u
ly
 2
0
0
8
 
the slope of the initial part of the survival curve
(as) and therefore the HRS phenomenon.
(2) A lack of control of RAD51-dependent pathway
in S-G2/M cells. However, since such a pathway
is active in S-G2/M cells only, its impact upon
HRS requires both sufficient fraction of S-G2/
M cells at the time of irradiation and failure to
arrest in cell cycle to allow propagation of
unrepaired DNA damage in cell cycle. It is
probable that such requirements are reached
after irradiation at 0.1 Gy whereas irradiation at
6 Gy would limit such propagation by longer
arrest in G2. Lastly, such an impairment would
be responsible for the production of additional
SSB, favoring the chromatin fragility and the
genomic instability in PRO cells and interfering
again into DNA repair and DNA damage
propagation.
The cellular consequences of such repair and cell
cycle deficiencies are cell death that may be either
mitotic death or p53-dependent apoptosis depending
on the genetic status of the irradiated cells. Alter-
natively, if there is no significant impairment in
NHEJ and RAD51-dependent repair pathways or
cell cycle arrest after irradiation, the HRS response is
low or absent (Figure 7). Interestingly, such require-
ments for HRS response were previously evoked in
the case of 19 tumour cell lines for high doses: The
tumour cell lines showing the most severe radio-
sensitivity should elicit both DNA repair and
chromatin defects. Any intermediate situation pro-
vides moderate radiosensitivity (Chavaudra et al.
2004). Further investigations are now needed to
identify what kind of DNA damage would cause
DNA repair deficiency and HRS response and
whether other highly metastatic clones deriving from
the same parental tumour cell line display similar or
different HRS mechanisms.
HRS response: Potential impact upon radiotherapy of
micrometastases
The HRS response was detected in many tumour
cell lines and a few normal cell lines when irradiated
at low-density (Joiner et al. 2001). Since tumour cells
irradiated at high-density were protected from HRS
response (Chandna et al. 2002), it is unlikely that
high-density primary or secondary tumours show
HRS response. An overview of radiobiological
reports in which HRS response was not specifically
investigated supports that inside a given tumour cell
line, highly metastatic clones are more radiosensitive
at high doses (i.e., higher than 0.5 Gy) than poorly
metastatic ones (Fu et al. 1976, Welch et al. 1983,
Rao et al. 1991, Barnetson et al. 1999). Moreover,
metastatic nodules to skin elicit marked HRS
response in vivo. However, in this particular case,
the mechanisms involved are still unclear since no
radiosensitivity data from nodules was provided
(Harney et al. 2004). We have previously shown that
the more the clones isolated from a same parental
human melanoma cell line are metastatic, the more
they show marked HRS response (Thomas et al.
1997). To better illustrate this concept, we re-
examined previous data from Thomas et al. (1997)
that were fitted to the IR and 2-pop LQ models
(Figure 8). Clone 4 with high metastatic potential
showed HRS response while clone 1 with low
metastatic potential did not. Variant 1 with inter-
mediate metastatic potential displayed both HRS
and IRR responses. However, these data were
obtained from cells at early passages and no HRS
response was observed at late passages (Thomas
et al. 1997). Similar conclusions were also reached
with PRO cells (data not shown). Our data suggest
therefore that HRS response is both an inherent
feature of micrometastases and a transient phenom-
enon, likely due to high genetic instability and
heterogeneity of micrometastases (Klein et al. 2002).
HRS response may find applications in
radiotherapy of micrometastases. Some early
Figure 7. Model for the HRS phenomenon.
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disseminated and probably unvascularised cells may
escape chemotherapy after excision of M0 primary
tumour. Evidence was provided that low-dose total
body irradiation (TBI) at doses lower than 20 cGy
reduces metastatic potential in rodents by immune
system stimulation (Hosoi & Sakamoto 1993, Ha-
shimoto et al. 1999, Liu 2003)). Since highly
metastatic cells may display HRS response, we
proposed to apply eventually a low-dose TBI after
excision of M0 primitive tumours to prevent micro-
metastases development (Thomas et al. 2001). To
test such hypothesis, the smallest dose producing
HRS response without increasing cancer must be
found. Very low doses such as 1.2 mGy may both
induce HRS response (Rothkamm & Lo¨brich 2003)
and reduce the risk of cancer transformation com-
pared to unirradiated cells (Azzam et al. 1996,
Redpath et al. 2003, Portless et al. 2007). In addition,
irradiation at 30 cGy X-rays applied to mice, whether
externally or in utero, did not show significant
increase of cancer (Di Majo et al. 2003). Epidemio-
logical data suggest that the lowest dose of X-or g-
radiation showing increased cancer risk in humans
may be situated between 10 and 50 mGy (Brenner
et al. 2003). Thus, even if literature data consolidate
the relevance of our hypothesis, the application of
preventive TBI treatments at very low dose (i.e.,
lower than 10 mGy) raises the problem of the
threshold dose in cancer incidence and requires
further and careful investigations. Studies using the
PRO/REG syngeneic model are in progress to secure
the applicability of preventive very low-doses TBI in
the radiotherapy of micrometastases.
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